WEISS MICHAEL S

CIK 00010389775 companiesMORRISVILLE, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001038977

Recent Transactions

50 trades

Gift
TG THERAPEUTICS, INC.$TGTX
Common Stock
2025-11-05−3,865,126→ 9,959,803 total
Gift
TG THERAPEUTICS, INC.$TGTX
Common Stock
2025-11-05−803,717→ 9,156,086 total
Award
TG THERAPEUTICS, INC.$TGTX
Common Stock (Restricted)
2017-01-01+418,371→ 9,452,167 total
Award
TG THERAPEUTICS, INC.$TGTX
Common Stock (Restricted)
2017-01-01+2,960,000→ 9,033,796 total
Disposition to Issuer
TG THERAPEUTICS, INC.$TGTX
Common Stock (Restricted)
2017-01-01−3,381,866→ 6,073,796 total
Award
TG THERAPEUTICS, INC.$TGTX
Common Stock (Restricted)
2017-01-01+2,960,000→ 9,033,796 total
Disposition to Issuer
TG THERAPEUTICS, INC.$TGTX
Common Stock (Restricted)
2017-01-01−3,381,866→ 6,073,796 total
Award
TG THERAPEUTICS, INC.$TGTX
Common Stock (Restricted)
2017-01-01+418,371→ 9,452,167 total
Award
TG THERAPEUTICS, INC.$TGTX
Common Stock (Restricted)
2016-12-30+693,750→ 10,145,917 total
Award
TG THERAPEUTICS, INC.$TGTX
Common Stock (Restricted)
2016-12-30+693,750→ 10,145,917 total
Award
Fortress Biotech, Inc.$FBIO
Common Stock, par value $0.001
2016-01-01+510,434→ 7,448,472 total
Award
Fortress Biotech, Inc.$FBIO
Common Stock, par value $0.001
2016-01-01+510,434→ 7,448,472 total
Award
TG THERAPEUTICS, INC.$TGTX
COMMON STOCK
2015-12-31+6,723,443→ 9,398,976 total
Award
TG THERAPEUTICS, INC.$TGTX
COMMON STOCK
2015-12-31+6,723,443→ 9,398,976 total
Award
TG THERAPEUTICS, INC.$TGTX
Common Stock
2015-12-31+672,343→ 9,398,976 total
Award
TG THERAPEUTICS, INC.$TGTX
Common Stock
2015-12-31+672,343→ 9,398,976 total
Award
TG THERAPEUTICS, INC.$TGTX
COMMON STOCK
2014-12-30+268,603→ 8,389,376 total
Award
TG THERAPEUTICS, INC.$TGTX
COMMON STOCK
2014-12-30+268,603→ 8,389,376 total
Award
TG THERAPEUTICS, INC.$TGTX
COMMON STOCK
2013-12-30+491,920→ 8,331,391 total
Award
TG THERAPEUTICS, INC.$TGTX
COMMON STOCK
2013-12-30+491,920→ 8,331,391 total
Award
TG THERAPEUTICS, INC.$TGTX
COMMON STOCK
2012-12-28+86,743→ 7,829,471 total
Award
TG THERAPEUTICS, INC.$TGTX
COMMON STOCK
2012-12-28+400,000→ 7,742,728 total
Award
TG THERAPEUTICS, INC.$TGTX
COMMON STOCK
2012-12-28+86,743→ 7,829,471 total
Award
TG THERAPEUTICS, INC.$TGTX
COMMON STOCK
2012-12-28+400,000→ 7,742,728 total
Purchase
KERYX BIOPHARMACEUTICALS INC
Common Stock
2008-08-26$0.41/sh+50,000→ 165,000 total
Purchase
KERYX BIOPHARMACEUTICALS INC
Common Stock
2008-08-26$0.41/sh+50,000→ 165,000 total
Purchase
KERYX BIOPHARMACEUTICALS INC
Common Stock
2008-08-22$0.40/sh+100,000→ 115,000 total
Purchase
KERYX BIOPHARMACEUTICALS INC
Common Stock
2008-08-22$0.40/sh+100,000→ 115,000 total
Award
KERYX BIOPHARMACEUTICALS INC
Stock Options (Right to Buy)
2007-12-30+198,375→ 198,375 total
Award
KERYX BIOPHARMACEUTICALS INC
Stock Options (Right to Buy)
2007-12-30+198,375→ 198,375 total
Award
KERYX BIOPHARMACEUTICALS INC
Stock Options (Right to Buy)
2006-01-02+1,500,000→ 1,500,000 total
Award
KERYX BIOPHARMACEUTICALS INC
Stock Options (Right to Buy)
2006-01-02+1,500,000→ 1,500,000 total
Gift
GENTA INC DE/
Common Stock, par value $.001
2005-08-05−400→ 537,238 total
Gift
GENTA INC DE/
Common Stock, par value $.001
2005-08-05−400→ 537,238 total
Award
GENTA INC DE/
Options to acquire Common Stock
2005-06-23+25,000→ 25,000 total
Gift
GENTA INC DE/
Common Stock, par value $.001
2005-06-08−17,500→ 537,638 total
Gift
GENTA INC DE/
Common Stock, par value $.001
2005-06-08−17,500→ 537,638 total
Award
KERYX BIOPHARMACEUTICALS INC
Stock Options (Right to Buy)
2005-01-03+500,000→ 500,000 total
Award
KERYX BIOPHARMACEUTICALS INC
Stock Options (Right to Buy)
2005-01-03+500,000→ 500,000 total
Gift
GENTA INC DE/
Common Stock, par value $.001
2004-07-14−500→ 564,588 total
Gift
GENTA INC DE/
Common Stock, par value $.001
2004-07-14−500→ 564,588 total
Gift
GENTA INC DE/
Common Stock, par value $.001
2003-12-17−9,600→ 591,838 total
Gift
GENTA INC DE/
Common Stock, par value $.001
2003-12-17−9,600→ 591,838 total
Award
GENTA INC DE/
Options to acquire Common Stock
2003-09-18+7,500→ 7,500 total
Award
GENTA INC DE/
Options to acquire Common Stock
2003-09-18+7,500→ 7,500 total
Award
GENTA INC DE/
Options to acquire Common Stock
2003-06-25+7,500→ 7,500 total
Award
GENTA INC DE/
Options to acquire Common Stock
2003-06-25+7,500→ 7,500 total
Purchase
KERYX BIOPHARMACEUTICALS INC
Common Stock
2003-06-04$1.75/sh+5,000→ 15,000 total
Purchase
KERYX BIOPHARMACEUTICALS INC
Common Stock
2003-06-04$1.75/sh+5,000→ 15,000 total
Award
KERYX BIOPHARMACEUTICALS INC
Stock Options (Right to Buy)
2002-12-23+4,050,000→ 4,050,000 total

Companies

Recent Filings

Address

3020 CARRINGTON MILL BLVD, SUITE 475

MORRISVILLE, NC, 27560

View on SEC.gov